Lululemon's Feud with Founder: 2026 Turnaround Prospects
A public clash over strategy and governance wrapped up for now, but 2026 could be a real test for lululemon. This inv...
What To Expect From Financial Planning Vs Accounting Services
Understand what to expect from financial planning and accounting services. Make informed decisions for your financial future.
23,685 articlesTrump Family’s $2.3B Crypto Windfall Shifts Market Narrative
New analysis shows the Trump family generated roughly $2.3 billion in pretax crypto income from late 2024 through Apr...
With Warsh’s Overhaul, Mortgage Rates Face New Risks
The Federal Reserve unveiled a sweeping policy overhaul under Chair Kevin Warsh, signaling a shift away from traditio...
MISMO Updates Mortgage Insurance Guide for Scoring Models
MISMO unveils updates to its Mortgage Insurance Implementation Guide to support VantageScore 4.0 and FICO 10T, aiming...
Forget Micron: Hynix IPO Now Steals the Spotlight Today
SK Hynix moves to list in the U.S., challenging Micron for memory-chip dominance as AI-driven demand and cyclical dyn...
Foreclosure Notice Sales Jump: What It Means for Investors
A sharp rise in foreclosure activity points to growing distress and new chances for investors. Learn what the foreclo...
OpenAI Says Shares Anthropic’s Red Lines on Military AI
OpenAI says shares Anthropic’s red lines on how the military can use AI, signaling a rare cross-firm consensus that c...
Arthur Hayes Deploys Liquidity: Waiting to Buy BTC
BitMEX co-founder Arthur Hayes signals he will not buy BTC now, citing a fragile liquidity backdrop and a need for Fe...
VIX Rips Higher as Oil Punches Through $100 Barrels, Markets Shiver
The VIX surges about 10% as Brent breaches the $100 mark, signaling rising fear among traders and a shift toward risk...
Gas Prices Keep Rising, but Will Big Oil Drill More?
Gas prices keep rising, but major oil companies have not signaled a surge in drilling to curb the pump. Here’s what d...
Daré (Dare) 2026 Earnings: A Comprehensive Investor Guide
As Daré gears up to discuss Q1 2026 results, investors will scrutinize cash runway, pipeline milestones, and strategi...
Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status